Literature DB >> 12741728

Predictive value of clinical features in differentiating group A beta-hemolytic streptococcal pharyngitis in children.

Meng-Hsun Lin1, Wen-Ki Fong, Pi-Feng Chang, Chih-Wei Yen, Koong-Lon Hung, Shwu-Jing Lin.   

Abstract

Identifying children with acute pharyngitis caused by group A beta-hemolytic Streptococcus (GABHS) is an important task for pediatricians. This study examined the value of certain clinical symptoms and signs in predicting a positive culture result. A total of 442 children who presented at the outpatient department with pharyngeal erythema were enrolled. The clinical features of patients with positive throat cultures for GABHS were compared to those with negative culture results. Throat cultures were positive for GABHS in 120 (27%) patients. Patients aged between 5 and 10 years had a higher prevalence of GABHS pharyngitis. Significant differences between the groups with and without GABHS pharyngitis were noted for the presence of sore throat (p < 0.001), tonsillar swelling (p < 0.001), anterior cervical adenopathy (p = 0.004), and scarlatiniform rash (p < 0.001), but not for the presence of fever, cough, rhinorrhea, abdominal pain, headache, tonsillar exudate, or palatal petechiae. Despite these strong associations, none of these symptoms or signs had both high sensitivity and specificity, and the positive predictive values of these individual findings were never greater than 50%. The results indicate that diagnosis based on clinical grounds alone is unreliable although there are certain individual symptoms and signs that are associated with GABHS pharyngitis. These symptoms and signs may be helpful in modifying estimates of probability of infection with GABHS. Throat cultures in suspected patients remain mandatory.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12741728

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  8 in total

1.  Performance of rapid streptococcal antigen testing varies by personnel.

Authors:  James W Fox; Daniel M Cohen; Mario J Marcon; William H Cotton; Bema K Bonsu
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

2.  Evaluation of Simplexa Group A Strep Direct Kit Compared to Hologic Group A Streptococcal Direct Assay for Detection of Group A Streptococcus in Throat Swabs.

Authors:  Deirdre L Church; Tracie Lloyd; Oscar Larios; Daniel B Gregson
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

3.  Acute post-streptococcal glomerulonephritis in a 14-month-old boy: why is this uncommon?

Authors:  Michael A Bingler; Demetrius Ellis; Michael L Moritz
Journal:  Pediatr Nephrol       Date:  2006-10-17       Impact factor: 3.714

4.  Validity of rapid antigen detection testing in group A beta-hemolytic streptococcal tonsillopharyngitis.

Authors:  Oznur Küçük; Suat Biçer; Tuba Giray; Defne Cöl; Gülay Ciler Erdağ; Yeşim Gürol; Ciğdem E Kaspar; Ayça Vitrinel
Journal:  Indian J Pediatr       Date:  2013-06-08       Impact factor: 1.967

5.  Streptococcal pharyngitis: a prospective study of compliance and complications.

Authors:  E Michael Sarrell; Shmuel M Giveon
Journal:  ISRN Pediatr       Date:  2012-06-21

6.  High diagnostic accuracy of automated rapid Strep A test reduces antibiotic prescriptions for children in the United Arab Emirates.

Authors:  Salama Bin Hendi; Zainab A Malik; Amar Hassan Khamis; Fadil Y A Al-Najjar
Journal:  BMC Pediatr       Date:  2021-01-25       Impact factor: 2.125

7.  Abdominal pain and nausea in the diagnosis of streptococcal pharyngitis in boys.

Authors:  Hiroshi Igarashi; Naoki Nago; Hiromichi Kiyokawa; Motoharu Fukushi
Journal:  Int J Gen Med       Date:  2017-09-22

8.  Diagnostic accuracy of QuickVue® Dipstick Strep A test and its effect on antibiotic prescribing in children in the United Arab Emirates.

Authors:  Seyed Ali Safizadeh Shabestari; Zainab A Malik; Fadil Y A Al-Najjar
Journal:  BMC Pediatr       Date:  2019-11-11       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.